Market Cap 438.18M
Revenue (ttm) 200.52M
Net Income (ttm) -306.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -152.97%
Debt to Equity Ratio 0.00
Volume 6,640,600
Avg Vol 10,657,586
Day's Range N/A - N/A
Shares Out 273.86M
Stochastic %K 2%
Beta 1.95
Analysts Sell
Price Target $3.00

Latest News on PACB

Pacific Biosciences' Cost Cuts Won't Offset Rising Competition

Nov 12, 2024, 3:38 PM EST - 2 months ago

Pacific Biosciences' Cost Cuts Won't Offset Rising Competition


PacBio to Present at Upcoming Investor Conferences

Nov 8, 2024, 4:05 PM EST - 2 months ago

PacBio to Present at Upcoming Investor Conferences


PacBio Grants Equity Incentive Award to New Employee

Sep 27, 2024, 4:05 PM EDT - 4 months ago

PacBio Grants Equity Incentive Award to New Employee